Search Results
52 items found for "Jonathan F Fay"
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
model of neuroinflammation Feasibility validation of Orion analogs in clinical development Cerini, F.
- Ode to GPCRs
Carl F. Cori and Mrs. Cori.
- Adhesion GPCR Consortium Newsletter - May 2024
Bandekar with help from Nathan Zaidman and Abhishek K. Singh
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
cardiomyocyte-specific Adhesion G Protein Coupled Receptor G1 (ADGRG1/GPR56) promotes pressure overload-induced heart failure
- 📰 GPCR Weekly News, June 24 to 30, 2024
Collaboration Targeting Neurological Diseases Achieves First R&D Milestone Tectonic bets on GPCR heart failure
- 📰 GPCR Weekly News, June 17 to 23, 2024
Monlunabant by Inversago Pharma for Metabolic Syndrome: Likelihood of Approval Tectonic bets on GPCR heart failure
- 📰 GPCR Weekly News, January 29 to February 4, 2024
on their work entitled β-arrestins and their potential role in heart failure. Dr. inflammatory diseases β-adrenergic receptor signaling mediated by β-arrestins and its potential role in heart failure
- Chemokine receptor-targeted drug discovery: progress and challenges
Different reviews have extensively described the success and failure in drug discovery on chemokine receptors
- 📰 GPCR Weekly News, October 2 to 8, 2023
development of databases supporting medical research ‘Define your own success’: Duke leaders talk success, failure
- 📰 GPCR Weekly News, July 17 to July 23, 2023
GPCRs in Oncology and Immunology A GPCR checkpoint drives CD8+ T cell dysfunction and immunotherapy failure
- 📰 GPCR Weekly News, June 12 to 18, 2023
and Immunology The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure
- 📰 GPCR Weekly News, June 5 to 11, 2023
Immunology and Oncology The GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure
- 📰 GPCR Weekly News, April 24 to 30, 2023
GPCRs in Cardiology, Endocrinology, and Taste Targeting G Protein-Coupled Receptors for Heart Failure
- 📰 GPCR Weekly News, March 27 to April 4, 2023
autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure
- 📰 GPCR Weekly News, February 20 to 26, 2023
Taste α1-Adrenergic Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure
- 📰 GPCR Weekly News, January 30 to February 5, 2023
autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
Treatment of cells with YM failed to inhibit signaling by these PM-restricted αqQ209L.
- G protein-coupled receptor kinase type 2 and β-arrestin2: Key players in immune cell functions...
β-arrestin2 play multiple roles in the pathological mechanisms of a wide range of diseases including heart failure
- Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...
On the contrary, in M2 cells, octreotide failed to internalize both receptors whereas pasireotide promoted
- Biased GPCR signaling by the native parathyroid hormone-related protein 1 to 141 relative to its...
interactions at the plasma membrane, PTHrP1-141 triggers sustained cAMP signaling from the plasma membrane and fails
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors
with MOR: morphine adjusted its pose by continuously flipping deeper into the pocket, whereas naloxone failed
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
In fact, it is often costly, frustrating, and tortuous—and more often than not it ends in failure.
- Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...
HLGR2 RNAi led to a low pupation rate (45.00%), body malformation, abnormal wing expansion, failed cuticle
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
Many cause receptor misfolding and failure to reach the cell surface.